SenesTech Revenue and Competitors

Phoenix, AZ USA

Location

$14.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SenesTech's estimated annual revenue is currently $7.5M per year.(i)
  • SenesTech's estimated revenue per employee is $153,061
  • SenesTech's total funding is $14.5M.

Employee Data

  • SenesTech has 49 Employees.(i)
  • SenesTech grew their employee count by 0% last year.

SenesTech's People

NameTitleEmail/Phone
1
CEO and ChairmanReveal Email/Phone
2
CEOReveal Email/Phone
3
CEOReveal Email/Phone
4
CEOReveal Email/Phone
5
EVP, Sales and MarketingReveal Email/Phone
6
Chief Financial Officer (CFO)Reveal Email/Phone
7
Chief Technical OfficerReveal Email/Phone
8
Director ManufacturingReveal Email/Phone
9
Chief Revenue OfficerReveal Email/Phone
10
Product DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$0.9M60%N/AN/A
#3
$0.8M5-29%N/AN/A
#4
$5.3M340%N/AN/A
#5
$2.5M16-20%N/AN/A
#6
$1.1M70%N/AN/A
#7
$0.9M60%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$171.9M1109-3%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is SenesTech?

SenesTech, Inc. (SenesTech) is a platform biotechnology company specializing in reproductive physiology. It\'s mission is to complete the development of non-surgical reproduction management technology that could profoundly change the world via wildlife and companion animal population control. We are currently applying our revolutionary technology to the control of the Southeast Asian Rice Rat in order to increase rice production. We believe that with the application of our product, ContraPest™, we will be able to feed at least an additional 380 million people annually within three years. SenesTech is developing strategic partnerships with international industry partners, non-profit institutions, and universities to accelerate the translation of its platform technology into marketable products within 15 months.

keywords:N/A

$14.5M

Total Funding

49

Number of Employees

$7.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SenesTech News

2022-04-13 - SenesTech, Inc. (NASDAQ:SNES) Short Interest Up 57.9% in ...

Citadel Advisors LLC grew its position in SenesTech by 53.2% in the 3rd quarter. Citadel Advisors LLC now owns 20,748 shares of the company's...

2022-03-30 - SenesTech Announces Year-End 2021 Financial and ...

SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology. News provided by. SenesTech, Inc. Mar 29, 2022,...

2022-03-30 - SenesTech, Inc. (SNES) CEO Kenneth Siegel On Q4 2021 Results - Earnings Call Transcript

SenesTech, Inc. (NASDAQ:SNES) Q4 2021 Earnings Conference Call March 29, 2022 5:00 PM ET. Company Participants.

2021-11-11 - SenesTech Announces 2021 Third Quarter Financial and Operational Results - Form 8-K

SenesTech Announces 2021 Third Quarter Financial and Operational Results Revenue More Than Doubles from the Third Quarter in 2020 and up 14% Sequentially PHOENIX, Ariz., November 10, 2021 SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility con ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.6M49-2%N/A
#2
$6.3M49N/AN/A
#3
$10.6M490%N/A
#4
$9.6M49-2%N/A
#5
$9.8M499%N/A